JDD Corner

Journal Review Series: April-June 2019
Journal Review Series
by ANNA H. CHACON, MD on
Next Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of April, May, and June of 2019. It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the literat …
April JDD Issue Highlights
April JDD
by NEXT STEPS IN DERM TEAM on
Here are the issue highlights and Editor Picks for the April issue of JDD: Dermatologists respond regarding the impact of COVID-19 and examine the potential impact of drugs on susceptibility and severity of infection in Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?   Treatment of Plaque Psoriasis With an Excimer Laser Utilizing a …
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
by NEXT STEPS IN DERM TEAM on
EPI Health has graciously supported the COVID-19 News and Resource Center. FREE WEBINAR: COVID-19: Urgent Medical and Aesthetic Issues for Dermatology Next Steps and JDD invites you to attend this webinar panel to provide discussion, guidance, and leadership for dermatologists and dermatology practices during the global coronavirus pandemic, COVID-19. Over the course of the 2 hours, 8 differe …
Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia
by NEXT STEPS IN DERM TEAM on
In this case series, JDD authors evaluate the efficacy and safety of intralesional triamcinolone acetonide injections (ILK) when used with topical minoxidil in the management of traction alopecia in 6 African American women. Background Traction alopecia (TA) is a form of hair loss secondary to repetitive and/or prolonged tension to a hair follicle over an extended period of time. This typically …
Compounding in Dermatology Update – Part 2
by NEXT STEPS IN DERM TEAM on
In part 1 of this 2-part series, Dr. Kircik along with JDD authors Vlatka Agnetta MD, Abel Torres MD JD MBA, Seemal R. Desai MD, and Adelaide A. Hebert MD, reviewed the regulatory landscape of compounding in dermatology, including federal and state regulations. In part 2, they discuss FDA and USP Compounding Lists/ Categories and provide their final thoughts on in-office compounding. FDA Compound …